La NMPA de China aprueba la Ivonescimab Injection para su comercialización

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#Ivonescimab #IvonescimabInjection #Yidafang #Akeso #AkesóBiofarmacéutica #NMPA #AprobaciónDeMedicamentos #Oncología #CáncerDePulmón #CPNM

🌟 #Yidafang (Ivonescimab): Dual Power in #NSCLC!
🎬 Watch how it boosts immunity & blocks tumor growth!
👇 Share your thoughts!

📩 info@dengyuemed.com
🔗 dengyuemed.com

#HongKongPharmaceuticaldistributor #Pharmaceuticaldistributorinchina
#Immunotherapy #Ivonescimab

🌟 #Yidafang (Ivonescimab):
Dual #PD-1 & #VEGF Target for #NSCLC! 🌟
💊 Boosts immunity,
blocks tumor growth,
improves survival.

🔗 Learn more: dengyuemed.com/product/ivon...

#HongKongDrugWholesaleDistributor #HongKongDengYueMedicine #Ivonescimab
#Immunotherapy #CancerTreatment